SU2C-supported trials seek to exteend CAR T-cell therapy to solid tumors - Stand Up To Cancer

News

SU2C-supported trials seek to exteend CAR T-cell therapy to solid tumors

Stand Up To Cancer is helping scientists make progress in one of the most important areas of cancer research today: expanding the use of autologous CAR T-cell immunotherapy beyond leukemia and other blood cancers to solid tumors, such as osteosarcoma and mesothelioma.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.